Tingling or numbness in the hands and feet is a common sign of peripheral neuropathy, a condition caused by damage to the peripheral nerves. If several peripheral nerves are damaged, you may have polyneuropathy. Many health conditions can cause polyneuropathy, including a type of amyloidosis called transthyretin amyloidosis polyneuropathy (ATTR-PN).
How do you know if that odd sensation means you have ATTR-PN or something else? Only a healthcare professional can diagnose you using a systematic evaluation, and they’ll rule out many other conditions along the way. This article provides an overview of polyneuropathy and some defining characteristics of ATTR-PN.
Medical professionals describe polyneuropathy as a type of peripheral neuropathy. Neuropathy means “nerve condition,” and the word “peripheral” refers to nerves outside the brain and spinal cord. The prefix “poly” means “many.”
So, a person with polyneuropathy has damage to multiple nerves outside the brain and spinal column that affect how those nerves work.
You may also hear the term “mononeuropathy.” This means just one nerve is affected in one area. Carpal tunnel syndrome is an example because it involves pressure on a single nerve in the wrist.
When several individual nerves are damaged in different areas, doctors call it mononeuritis multiplex. This is different from having carpal tunnel syndrome in both wrists, which is considered two separate mononeuropathies rather than mononeuritis multiplex. Polyneuropathy is more common than mononeuropathy.
Polyneuropathy symptoms vary depending on which nerves are affected. Damaged nerves can interfere with many body functions, such as digestion, or cause symptoms like pain, numbness, or tingling.
The nerves farthest from the brain tend to be affected first, so symptoms often begin in the feet. Because the longest nerve fibers in the body require the most energy to stay healthy, damage often begins in the toes and feet before gradually moving up the legs and may eventually affect the hands. This pattern is called length-dependent neuropathy.
Polyneuropathy symptoms may include:
Polyneuropathy is often caused by chronic (long-term) conditions that affect the entire body. Injuries can also damage multiple nerves.
Common causes of polyneuropathy include:
When healthcare professionals can’t identify the cause of nerve damage, it’s called idiopathic neuropathy or cryptogenic neuropathy. Between 25 percent and 46 percent of polyneuropathy cases are idiopathic.
According to the National Institute of Neurological Disorders and Stroke, there are more than 100 types of neuropathy. Healthcare professionals group them into several broad categories, and some types fit into more than one category.
One way to classify neuropathy is by the type of nerve that is affected:
Neuropathy can also be described as inherited or acquired:
Neuropathy may also be described as chronic, meaning it develops slowly or lasts a long time, or acute, meaning it develops suddenly over days or weeks.
Healthcare professionals may also describe peripheral neuropathy by its underlying cause or its main features. Common examples include:
Many other terms may be used to describe polyneuropathy based on its cause, the nerves involved, or how it affects the body. A neurologist can explain the specific type of polyneuropathy you have and what it means for your care.
The underlying cause of ATTR-PN sets it apart from other types of neuropathy. ATTR-PN develops when transthyretin (TTR) proteins become unstable, misfold, and build up as amyloid deposits in tissues throughout the body. These amyloid deposits damage nerves directly and can also reduce the blood supply that nerves need to stay healthy, leading to nerve damage over time.
Proteins also play a role in some other types of neuropathy, but in different ways. For example, monoclonal gammopathy of undetermined significance (MGUS) causes the body to make an abnormal protein. In some people, this protein can damage nerves and cause neuropathy.
MGUS can also progress to AL amyloidosis. It’s important to tell AL amyloidosis apart from ATTR-PN because their treatments are very different.
Some neuropathies mainly affect one type of nerve. These are called pure motor neuropathy, pure autonomic neuropathy, or pure sensory neuropathy.
ATTR-PN usually affects several types of peripheral nerves. Sensory nerves are often affected first, but motor and autonomic nerves may also become involved as the disease progresses.
ATTR-PN is a progressive disease, meaning it tends to get worse over time if left untreated. Unlike some other forms of polyneuropathy, ATTR-PN doesn,t have a cure.
Treatment for ATTR-PN focuses on slowing or stopping the buildup of amyloid. Disease-modifying therapies approved by the U.S. Food and Drug Administration (FDA), including eplontersen (Wainua) and vutrisiran (Amvuttra), reduce the liver’s production of TTR, helping slow nerve damage.
Because polyneuropathy has many different causes, treatment depends on the underlying condition. Medications, physical therapy, and other supportive treatments may also help manage symptoms and improve quality of life.
Healthcare professionals use several tests to determine the cause of polyneuropathy.
Your doctor will begin by asking about your symptoms, medical history, and family medical history. Your diet, medications, and lifestyle may also provide important clues.
Next, they’ll perform a physical and neurological exam. They’ll check for sensation in your hands and feet and look for muscle weakness, balance problems, or changes in your walking pattern.
Blood tests, nerve conduction studies, and imaging tests may help pinpoint the cause of polyneuropathy. To diagnose ATTR-PN, your doctor may also recommend genetic testing and, in some cases, a tissue biopsy or specialized heart imaging to look for amyloid deposits.
Even with today’s diagnostic tools, sometimes the cause of polyneuropathy remains a mystery.
Treating polyneuropathy is much easier when healthcare professionals know what’s causing it. Finding the underlying cause also helps doctors predict how the condition may progress and what parts of the body may be affected.
For people with ATTR-PN, getting an early diagnosis is especially important. Disease-modifying therapies work best when started early, before nerve damage occurs. Starting treatment early may help slow disease progression, preserve nerve function, and maintain quality of life for longer.

On MyAmyloidosisTeam, people share their experiences with amyloidosis, get advice, and find support from others who understand.
What neuropathy symptoms have you experienced with amyloidosis? Let others know in the comments below.
Get updates directly to your inbox.
Become a member to get even more
This is a member-feature!
Sign up for free to view article comments.
We'd love to hear from you! Please share your name and email to post and read comments.
You'll also get the latest articles directly to your inbox.